News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-07 7:24:30 pm Lineage Cell Therapeutics, Inc. (LCTX) Q4 2023 Earnings Call Transcript SeekingAlpha
2024-03-07 1:1:0 pm Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update Business Wire
2024-02-29 5:0:0 am Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 7, 2024 Business Wire
2024-02-13 5:0:0 am Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury Business Wire
2024-02-09 6:15:0 am Lineage Cell Therapeutics Announces Closing of $14.0 Million Registered Direct Offering Business Wire
2024-02-06 6:15:0 am Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering Business Wire
2024-01-16 5:0:0 am RG6501 (OpRegen®) Phase 1/2a Results Will Be Featured at 2024 Angiogenesis Exudation and Degeneration Meeting in Presentation by Allen Ho, MD, FACS, FASRS Business Wire
2023-12-18 5:0:0 am Lineage Announces Submission of OPC1 Investigational New Drug Amendment for Treatment of Chronic and Subacute Spinal Cord Injury Business Wire
   

Please consider a small donation if you think this website provides you with relevant information